Optimizing treatment of diabetes and cardiovascular disease with combined α,β‐blockade
- 17 June 2005
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 21 (8), 1191-1200
- https://doi.org/10.1185/030079905x53306
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trialsAmerican Heart Journal, 2003
- Diabetic CardiomyopathyDiabetes Care, 2003
- Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1Proceedings of the National Academy of Sciences, 2003
- Obesity, Hypertension, and Insulin ResistanceDiabetes Care, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart FailureJournal of the American College of Cardiology, 1997
- Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivityJournal Of Hypertension, 1996
- Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose toleranceThe American Journal of Cardiology, 1995
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979